Have you been recently diagnosed with T1D? You may be able to participate in a research study for an investigational cell therapy product to see if it is safe for patients with T1D and to see if it helps to slow down the progression of T1D.

The purpose of this study is to evaluate the distribution of a human leukocyte antigen genotype in adults who were recently diagnosed with type 1 diabetes

The purpose of this study is to determine if an investigational treatment can address the underlying cause of Graves' disease, and potentially normalize thyroid hormone levels.

This study is being done to see if an investigational medication works better than a placebo (dummy medicine) for weight loss.

Many patients with type 2 diabetes do not achieve their goals for managing their blood sugar and are therefore at risk for developing complications, despite treatment with insulin and other medications for diabetes. Automated insulin delivery systems have been shown to be beneficial for patients with type 1 diabetes, and may be equally beneficial for patients with type 2 diabetes.

The purpose of this study is to determine the efficacy and safety of an investigational oral medication compared with placebo in people with obesity or overweight with and without type 2 diabetes

Do you have type 1 diabetes? Has your doctor told you that your HbA1c is higher than the goal? Do you also have excess body weight? If you are having a hard time controlling your blood sugar with only insulin, you may be able to participate in a research study to see if taking an investigational medication once weekly can help improve your blood sugar control and reduce your body weight.

The purpose of this study is to see how prevalent high cortisol levels are in people with high blood pressure that is resistant to treatment.

What factors influence how the brain takes in sugar to use it as energy? If you are between the ages of 18-45 years old and are healthy and of normal weight, you might be eligible to participate in this study to help us understand how the way sugar enters the body affects how sugar enters the brain.

This study aims to investigate the effectiveness and safety of retatrutide, a new diabetes medication) at doses of 4 mg, 9 mg, or 12 mg that will be taken as a weekly injection for about 1 year, compared to a placebo. A participant's change in HbA1c level will be primary outcome of interest. We are seeking participants with type 2 diabetes that has affected kidney function and are currently taking long-acting insulin with metformin and/or a SGLT2 inhibitor.